Tanaka Tomohiro, Nomura Wataru, Narumi Tetsuo, Esaka Ai, Oishi Shinya, Ohashi Nami, Itotani Kyoko, Evans Barry J, Wang Zi-xuan, Peiper Stephen C, Fujii Nobutaka, Tamamura Hirokazu
Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo, 101-0062, Japan.
Org Biomol Chem. 2009 Sep 21;7(18):3805-9. doi: 10.1039/b908286g. Epub 2009 Jul 20.
Previously, downsizing of a 14-residue peptidic CXCR4 antagonist has led to the development of a highly potent CXCR4 antagonist [cyclo(-d-Tyr(1)-Arg(2)-Arg(3)-Nal(4)-Gly(5)-)]. In the present study, cyclic pentapeptide libraries that were designed by substitutions of several amino acids for d-Tyr(1) and Arg(2) in peptide were prepared and screened to evaluate binding activity for CXCR4. The above structure-activity relationship study led to the finding of several potent CXCR4 ligands.
此前,一种14个残基的肽类CXCR4拮抗剂的缩小编导致了一种高效CXCR4拮抗剂[环(-d-酪氨酸(1)-精氨酸(2)-精氨酸(3)-萘丙氨酸(4)-甘氨酸(5)-)]的开发。在本研究中,通过用几种氨基酸替代肽中的d-酪氨酸(1)和精氨酸(2)设计了环状五肽文库,并进行筛选以评估其对CXCR4的结合活性。上述构效关系研究导致发现了几种有效的CXCR4配体。